News

Krishnan Nandabalan, CEO of InveniAI, discusses how artificial intelligence is shifting the clinical trial paradigm in studies for areas like oncology and the central nervous system.

Irfan Khan, writes that though we celebrate MyStudies' teams work, the FDA’s Patient Engagement Advisory Council deserves specific credit for bringing the patient voice into the design thinking for technologies in clinical research.

Barbara Lopez Kunz, Global Chief Executive at the Drug Information Association discusses how involvement of patients in healthcare is critical for success.

PhRMA in Europe cries of trailing the US after adopting reference pricing.

Moe Alsumidaie interviews Sandy Macrae, Chief Executive Officer of Sangamo Therapeutics, Inc., who discusses navigating the new wave of genomic medicine.

Chris Barker, an Independent Statistical Consultant, discusses the differences and biases in summaries obtained from a database called PDQ vs. CTG.

Sandra Pagnussat, of QPS, explores strategies to help combat the unique set of challenges that pediatric trials present.

Do patients really want to share their data? Nearly half of the rare disease patients responding to an international survey, are against their data being shared outside or even within the medical field.